The results suggested that HQT has protective effect against hepatic steatosis and inflammation in NAFLD rats by attenuating ER stress, and the potential mechanism is through inhibition of PERK and ATF6 pathways. The gene discussed is EIF2AK3; the disease is metabolic dysfunction-associated steatotic liver disease.